Company: HRTX
Filing Date: 2025-02-27
Form Type: 10-K
Source: 0000950170-25-028374
Chunk: 126

Company: HERON THERAPEUTICS, INC. /DE/
Filing Date: 2025-02-27
Form: 10-K
Item: Item 1B
Chunk 126
---
 GrossUnrealizedGains

        GrossUnrealizedLosses

        EstimatedFair Value

        U.S. treasury bills and government agency obligations
         
        $
        31,625

        $
        11

        $
        —

        $
        31,636

        U.S. corporate debt securities

        11,652

        1

        —

        11,653

        Foreign corporate debt securities

        5,459

        1

        —

        5,460

        U.S. commercial paper

        1,990

        —

        —

        1,990

        Foreign commercial paper

        993

        —

        —

        993

        Total
         
        $
        51,719

        $
        13

        $
        —

        $
        51,732

      The amortized cost of debt securities is adjusted for amortization of premiums and accretion of discounts to maturity. We regularly monitor and evaluate the realizable value of our marketable securities. We did not recognize any impairment losses for the years ended December 31, 2024 and 2023.Unrealized gains and losses associated with our investments are reported in accumulated other comprehensive income (loss). For the year ended December 31, 2024, we recorded no net unrealized gains or losses associated with our short-term investments. For the year ended December 31, 2023, we recorded $32,000 in net unrealized losses associated with our short-term investments.Realized gains and losses associated with our investments, if any, are reported in the statements of operations and comprehensive loss. We recognized $5,000 in realized gains during the year ended December 31, 2024, $1,000 in realized losses during the year ended December 31, 2023.  We did not recognize any realized gains or losses during the year ended December 31, 2022.InventoryInventory consists of the following (in thousands): 

        December 31,

        2024

        2023

        Raw materials
         
        $
        19,733

        $
        17,643

        Work in process

        27,190

        14,550

        Finished goods

        6,237

        9,917

        Total inventory
         
        $
        53,160

        $
        42,110

85

As of December